DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



CT Homepage

Congress to evaluate bill on CT colonography coverage Would expand coverage of CT colonography for colorectal cancer

NIH grants over $1 million to development of non-contrast imaging approaches Will be used to diagnose peripheral arterial disease

China's Infervision brings AI tech to 200th hospital Now in use with approx. 20,000 lung cancer screening scans daily

Philips to manage medical imaging equipment for Aussie providers for 20 years First-of-its-kind partnership in Australia and ASEAN Pacific region

New AI system detects hard-to-see tiny tumors on lung CT scans Teaches itself how to locate tiny tumors

Fractional flow reserve CT can reduce invasive heart procedures: study First clinical study on benefits of FFRCT for moderate stenosis

Fox Chase Cancer Center gets $673K grant to develop early-stage lung cancer test Taking aim at false positive CT lung scans

Patient-physician discussions on lung cancer screenings are inadequate Study finds they don't address potential harm and false positives

Philips partners with Intel on CPU efficiency for medical imaging use cases Pairs Philips' OpenVINO toolkit with Intel Xeon Scalable processors

Study: AI detects neurological issues on CT scans in under two seconds 150 times shorter than average reading time of a physician

Coalition urges CMS clarification on low dose CT guidance

by Thomas Dworetzky , Contributing Reporter
The American College of Radiology (ACR) and other partner groups have sent a formal letter to the U.S. Centers for Medicare and Medicaid Services (CMS) requesting that it confirm that Medicare will reimburse for CT lung cancer screening at Independent Diagnostic Testing Facilities (IDTF).

Its partners include the Radiology Business Management Association (RBMA), the Healthcare Business Management Association (HBMA) the Association for Quality Imaging (AQI), Medical Imaging and Technology Alliance (MITA), and Lung Cancer Alliance (LCA).

Story Continues Below Advertisement


Special-Pricing Available on Medical Displays, Patient Monitors, Recorders, Printers, Media, Ultrasound Machines, and Cameras.This includes Top Brands such as SONY, BARCO, NDS, NEC, LG, EDAN, EIZO, ELO, FSN, PANASONIC, MITSUBISHI, OLYMPUS, & WIDE.

“We believe that Medicare Administrative Contractors (MACs) are not correctly adhering to the lung cancer screening NCD 210.14. In accordance with the June 12, 2017 Medicare Learning Network Matters article (MM9246), CMS clarified that IDTFs are, in fact, eligible facilities capable of performing low-dose computed tomography (LDCT) lung cancer screening. Nevertheless, MACs regularly exclude LDCT lung cancer screening coverage when performed in the IDTF setting, including at sites that meet the NCD criteria. We hope CMS can clarify these outstanding issues contributing to the MACs’ decision to deny coverage of LDCT lung screening at IDTFs,” the letter stated.

ACR noted in a May 18th statement that physician ignorance of screening guidelines, lack of patient and physician education about screening and “drastically low Medicare reimbursement for low-dose computed tomography (LDCT) lung cancer screening exams” may be resulting in thousands of unnecessary deaths each year.

“CT lung cancer screening can save more lives than any cancer screening test in history, but patients are not hearing about this test from their doctors,” said Dr. Ella Kazerooni, ACR Lung Cancer Screening Committee Chair, in a statement. “Medicare is not adequately covering these exams. This noncompliance and practical non-coverage is contributing to unnecessary deaths due to lack of screening.”

The ACR letter to CMS requested clarification and advised that MACs are misinterpreting the regulations by “erroneously” excluding the screening exams.

“MACs continue to approve payment to IDTFs for 71250 (non-contrast chest CT), while denying LDCT lung cancer screen (G0297), despite being the same type of service (e.g., chest CT). The MACs state that IDTFs are for diagnostic testing, rather than screening.”

The coalition members view this narrow definition of diagnostic exam as erroneous. The MACs, according to the letter, continue to view the screens as “therapeutic intervention.” The coalition letter requested that CMS issue a notice to MACs establishing that they are, in fact, diagnostic, a preventive screening available to Medicare users, that it should be covered wherever it is given, including IDTFs, and that payment should go back to February 5, 2015.
  Pages: 1 - 2 >>

CT Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.